Antidepressant-like activity of n-hexane extract of nutmeg (Myristica fragrans) seeds in mice

被引:51
作者
Dhingra, D [1 ]
Sharma, A [1 ]
机构
[1] Guru Jambheshwar Univ, Dept Pharmaceut Sci, Div Pharmacol, Hisar 125001, Haryana, India
关键词
depression; forced swim test; Myristica fragrans; tail suspension test;
D O I
10.1089/jmf.2006.9.84
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The present study was undertaken to investigate the effect of an n-hexane extract of Myristica fragrans seeds on depression in mice by using the forced swim test (FST) and the tail suspension test (TST). M. fragrans extract (5, 10, and 20 mg/kg) was administered orally for 3 successive days to different groups of Swiss male young albino mice. M. fragrans extract significantly decreased immobility periods of mice in both the FST and the TST. The 10 mg/kg dose was found to be most potent, as indicated by the greatest decrease in the immobility period compared with the control. Furthermore, this dose of the extract was found to have comparable potency to imipramine (15 mg/kg i.p.) and fluoxetine (20 mg/kg i.p.). The extract did not have a significant effect on locomotor activity of mice. Prazosin (62.5 mu g/kg i.p.; an alpha(1)-adrenoceptor antagonist), sulpiride (50 mg/kg i.p.; a selective D-2 receptor antagonist), and p-chlorophenylalanine (100 mg/kg i.p.; an inhibitor of serotonin synthesis) significantly attenuated the M. fragrans extract-induced antidepressant-like effect in the TST. Thus, extract of M. fragrans elicited a significant antidepressant-like effect in mice, when assessed in both the TST and the FST. The antidepressant-like effect of the extract seems to be mediated by interaction with the adrenergic, dopaminergic, and serotonergic systems.
引用
收藏
页码:84 / 89
页数:6
相关论文
共 37 条
[31]   THE TAIL SUSPENSION TEST - A NEW METHOD FOR SCREENING ANTIDEPRESSANTS IN MICE [J].
STERU, L ;
CHERMAT, R ;
THIERRY, B ;
SIMON, P .
PSYCHOPHARMACOLOGY, 1985, 85 (03) :367-370
[32]   Alpha-1-noradrenergic neurotransmission, corticosterone, and behavioral depression [J].
Stone, EA ;
Quartermain, D .
BIOLOGICAL PSYCHIATRY, 1999, 46 (09) :1287-1300
[33]  
THIERRY B, 1986, PSYCHOPHARMACOLOGY, V90, P284
[34]   THE VALIDITY OF ANIMAL-MODELS OF DEPRESSION [J].
WILLNER, P .
PSYCHOPHARMACOLOGY, 1984, 83 (01) :1-16
[35]   ANIMAL-MODELS AS SIMULATIONS OF DEPRESSION [J].
WILLNER, P .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1991, 12 (04) :131-136
[36]   Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test [J].
Yamada, J ;
Sugimoto, Y ;
Yamada, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 504 (03) :207-211
[37]   An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression [J].
Zarate, CA ;
Quiroz, JA ;
Singh, JB ;
Denicoff, KD ;
De Jesus, G ;
Luckenbaugh, DA ;
Charney, DS ;
Manji, HK .
BIOLOGICAL PSYCHIATRY, 2005, 57 (04) :430-432